Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC, 10830 [2025-03170]
Download as PDF
<![CDATA[
10830
Federal Register / Vol. 90, No. 38 / Thursday, February 27, 2025 / Notices
confidential treatment by the
Commission is properly sought will be
treated accordingly. Any non-party
wishing to submit comments containing
confidential information must serve
those comments on the parties to the
investigation pursuant to the applicable
Administrative Protective Order. A
redacted non-confidential version of the
document must also be filed
simultaneously with any confidential
filing and must be served in accordance
with Commission Rule 210.4(f)(7)(ii)(A)
(19 CFR 210.4(f)(7)(ii)(A)). All
information, including confidential
business information and documents for
which confidential treatment is properly
sought, submitted to the Commission for
purposes of this investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All nonconfidential written
submissions will be available for public
inspection on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and in Part 210 of the Commission’s
Rules of Practice and Procedure (19 CFR
Part 210).
By order of the Commission.
Issued: February 21, 2025.
Lisa Barton,
Secretary to the Commission.
1930 (‘‘the Act’’), that revocation of the
antidumping duty orders on certain
stilbenic optical brightening agents from
China and Taiwan would be likely to
lead to continuation or recurrence of
material injury to an industry in the
United States within a reasonably
foreseeable time.
Background
The Commission previously instituted
these second five-year reviews on
October 2, 2022 (87 FR 59827), but
subsequently terminated the reviews on
January 13, 2023 (88 FR 2374) following
Commerce’s final results of sunset
reviews and revocation of the orders on
certain stilbenic optical brightening
agents from China and Taiwan (87 FR
80162, December 29, 2022). Following
an appeal by domestic producer
Archroma U.S., Inc., the U.S. Court of
International Trade directed Commerce
and the Commission to undertake
reviews of the orders. See Archroma
U.S., Inc. v. U.S. Dep’t of Commerce, et
al., 703 F. Supp. 3d 1396, 1403–04 (Ct.
Int’l Trade 2024). The Commission
reinstituted these reviews on July 1,
2024 (89 FR 54525) and determined on
October 7, 2024 that it would conduct
expedited reviews (89 FR 88303,
November 7, 2024).
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on February 21, 2025.
The views of the Commission are
contained in USITC Publication 5591
(February 2025), entitled Certain
Stilbenic Optical Brightening Agents
from China and Taiwan: Investigation
Nos. 731–TA–1186–1187 (Second
Review).
By order of the Commission.
Issued: February 21, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025–03156 Filed 2–26–25; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
ddrumheller on DSK120RN23PROD with NOTICES1
Certain Stilbenic Optical Brightening
Agents From China and Taiwan
[Docket No. DEA–1445]
Determinations
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1 The
record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
17:01 Feb 26, 2025
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 30, 2024,
Groff NA Hemplex LLC, 2218 South
Queen Street, York, Pennsylvania
17402, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Drug
code
Schedule
7350
7360
7370
I
I
I
BILLING CODE 7020–02–P
[Investigation Nos. 731–TA–1186–1187
(Second Review)]
VerDate Sep<11>2014
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 28, 2025, Such
persons may also file a written request
for a hearing on the application on or
before April 28, 2025.
DATES:
Controlled substance
[FR Doc. 2025–03148 Filed 2–26–25; 8:45 am]
INTERNATIONAL TRADE
COMMISSION
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
Jkt 265001
Bulk Manufacturer of Controlled
Substances Application: Groff NA
Hemplex LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The company is federally authorized
to conduct cultivation activities in order
to bulk manufacture the listed
controlled substances for internal use
and for sale to federally registered
research investigators. No other
activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–03170 Filed 2–26–25; 8:45 am]
BILLING CODE P
Groff Hemplex LLC has
applied to be registered as a bulk
SUMMARY:
PO 00000
Frm 00024
Fmt 4703
Sfmt 9990
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 90, Number 38 (Thursday, February 27, 2025)]
[Notices]
[Page 10830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03170]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1445]
Bulk Manufacturer of Controlled Substances Application: Groff NA
Hemplex LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Groff Hemplex LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 28, 2025, Such persons may also file a written request for a
hearing on the application on or before April 28, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 30, 2024, Groff NA Hemplex LLC, 2218 South
Queen Street, York, Pennsylvania 17402, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company is federally authorized to conduct cultivation
activities in order to bulk manufacture the listed controlled
substances for internal use and for sale to federally registered
research investigators. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-03170 Filed 2-26-25; 8:45 am]
BILLING CODE P
